S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2018-11	Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin -H.; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Ffrank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay New England Journal of Medicine, Vol.379 No.21, pp.2027-2039	DOI
2022-12	Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2) Ou, Sai-Hong Ignatius; Nishio, Makoto; Ahn, Myung-Ju; Mok, Tony; Barlesi, Fabrice; Zhou, Caicun; Felip, Enriqueta; de Marinis, Filippo; Kim, Sang-We; Perol, Maurice; Liu, Geoffrey; Migliorino, Maria Rita; Kim, Dong Wan; Novello, Silvia; Bearz, Alessandra; Garrido, Pilar; Mazieres, Julien; Morabito, Alessandro; Lin, Huamao M.; Yang, Hui; Niu, Huifeng; Zhang, Pingkuan; Kim, Edward S. Journal of Thoracic Oncology, Vol.17 No.12, pp.1404-1414	DOI